Product Information

RIVAROXABAN 2.5 MG TABLET is a generic product labeled by Apotex Corp., priced at $0.5989 per EA under NDC 60505625606. Its NADAC has been published 72 times since Jul 9, 2025.

FDA first approved this application on May 2, 2025. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

RIVAROXABAN 2.5 MG TABLET

Rivaroxaban
$0.5989per EA

Strength

2.5 mg/1

Manufacturer

Apotex Corp.

NDC

60505625606

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

RIVAROXABAN

Approval Type

Generic (ANDA)

FDA Application

ANDA217810

FDA Approved

5/2/2025

TE Code

AB

On Market Since

5/2/2025

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for RIVAROXABAN 2.5 MG TABLET has been published 72 times since Jul 9, 2025, and over the history we have for it it has declined 86.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.5989 per EA
All-time high$4.6446 (Aug 13, 2025)
All-time low$0.5989 (Nov 18, 2026)
52-week high$1.6224
52-week low$0.5989
Median price$1.0274
Average price$1.6940
Largest weekly change-32.4% (Nov 19, 2025)
Weeks tracked72
Tracking sinceJul 9, 2025

Price History

1W

-4.4%

1M

-7.8%

3M

-8.7%

6M

-31.4%

1Y

-63.1%

3Y

N/A

5Y

N/A

All

-86.9%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of RIVAROXABAN 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RIVAROXABAN 2.5 MG TABLET, manufactured by Apotex Corp., is $0.5989 per EA (NDC 60505625606), effective Nov 18, 2026.

How has the price of RIVAROXABAN 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for RIVAROXABAN 2.5 MG TABLET has declined 86.9%. It has been tracked across 72 weekly CMS publications since Jul 9, 2025.

What are the highest and lowest recorded NADAC prices for RIVAROXABAN 2.5 MG TABLET?

Since Jul 9, 2025, the NADAC for RIVAROXABAN 2.5 MG TABLET has ranged from a low of $0.5989 (Nov 18, 2026) to a high of $4.6446 (Aug 13, 2025), with a median of $1.0274 per EA.

Are there cheaper alternatives to RIVAROXABAN 2.5 MG TABLET?

6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as RIVAROXABAN 2.5 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures RIVAROXABAN 2.5 MG TABLET?

RIVAROXABAN 2.5 MG TABLET (NDC 60505625606) is labeled by Apotex Corp., and CMS classifies it as a generic product.